Tags Posts tagged with "Medicine"

Medicine

0 3428

There seems to be some confusion amongst the leaders of this incredible country.

In late February, White House press secretary Sean Spicer made an uneducated and informed connection between the opioid addiction crisis we currently face and recreational cannabis.

Spicer said, “There’s a big difference between that and recreational marijuana. I think that when you see the opioid addiction crisis blossoming in so many states around this country, the last thing we should be doing is encouraging people. There is still a federal law we need to abide by in terms of when it comes to recreational marijuana.”

Providing Real Facts…Not the Alternative Kind

In January, the National Academies of Sciences, Engineering and Medicine released a review of 10,000 medical cannabis studies published since 1999. The results strongly support the use of cannabis for the treatment of chronic pain.

In 2014, John Hopkins published a report that found the annual number of deaths from prescription drug overdose is 25% lower than in states where medical marijuana remains illegal.

Several reports actually link the opioid crisis we are currently facing to big pharmaceutical companies that liberally prescribed drugs like Oxycontin and Vicodin.

In late December, Department of Justice said several former employees of Insys Therapeutics (INSY), including its former CEO and president, had been arrested and charged with bribing doctors and defrauding health insurers to push prescriptions of Subsys, a fentanyl sublingual spray that has led to countless overdoses.

Biotech Stocks to Watch

The opioid crisis the United States faces combined with recent breakthroughs in research pertaining to the medical benefits of cannabis have created several attractive opportunities for biotech investors.

Some of the companies investors should be watching Future Farm Technologies Inc. (FFT.CN) (FFRMF), Vinergy (VIN.CN) (VNNYF), and InMed Pharmaceuticals Inc. (IN.CN) (IMLFF).

0 1834

Those who consume cannabis as adolescents may have a more difficult time remembering words as they grow up to become adults, a new study indicates. Yet cannabis use does not seem to have a negative impact on other mental capacities, such as the ability to think swiftly, concentrate or solve problems, according to the authors of the study.

“We were really surprised by the findings,” Dr. Reto Auer, author of the study and “academic chief resident in the department of community medicine and ambulatory care at the University of Lausanne,” in Switzerland, stated. Marijuana’s effects on the ability to remember vocabulary seems to be “incremental, meaning that the more you smoke, the lower your verbal memory,” Auer added.

Despite this, he made it a point that the results “are only associations,” and not evidence that marijuana has this effect. Auer stated that the experiment only saw marijuana’s effects on lexical memory rather than overall memory. The study also didn’t examine whether subjects or their kin though that marijuana had this effect. The findings were published on February 1st, in the online edition of JAMA Internal Medicine.

To observe the possible long-term impact of cannabis use, the researchers looked at 3,400 white and black men and women who were between the ages of 18 and 30 when they first enrolled in an international study in 1985 and 1986. The subjects were from Birmingham, Ala.; Chicago; Minneapolis; or Oakland, Calif. Also, they were all studies for the next quarter of a century till 2011. At that time cannabis use was reported and had interviews afterwards.

About eighty-five percent of the research subjects said they had smoked marijuana at some time, and about twelve percent reported that they consistently did so until they reached their thirties. Cognitive skills were studied at the end of the twenty-five years.

0 1280

 

Another study finds that joining the medication topiramate with psychological directing stopped weed addiction among youthful smokers essentially more than therapy alone. In the small randomized control trial Brown University scientists, then again, found that numerous study volunteers were not able to endure the pharmaceutical’s reactions. At the moment, there is no FDA-affirmed prescription for treating cannabis reliance and abuse. As of right now, the advantages of advising treatment, for example, motivational enhancement therapy (MET), aren’t sufficient to offer numerous patients, some assistance with saying Robert Miranda Jr., partner educator of psychiatry and human conduct in the Alpert Medical School.

Miranda and his co-creators directed the trial as the first test to figure out if topiramate, an epilepsy drug showcased as Topamax, could add to the goods of conventional treatment. Topiramate has been considered as a potential treatment for liquor and nicotine reliance as well as cocaine addiction. In spite of the fact that scientists found that topiramate didn’t diminish the recurrence of smoking essentially more than treatment alone, studies on members who got the drug and MET utilized less cannabis every time on average than members who got guiding and a fake treatment.

“The positive news is it did seem to have some effect, and that effect seemed to be really focused on helping people reduce how much they smoke when they smoke,” Miranda, lead author of the study in the journal Addiction Biology, said. “It’s promising in the sense that it suggests that medications can help, but it asks questions about for whom it might be most effective because many people can’t tolerate the medication.”

The pilot study was the first to test topiramate for cannabis reliance. Specialists selected 66 volunteers, from the ages of 15-24, who smoked in any event twice weekly yet were occupied in getting mental and drug treatment to diminish cannabis use. Overwhelming pot use is connected with debilitated memory and official intellectual capacity, trouble supporting consideration and sifting through insignificant data. Introductory screening demonstrated that more than half of the members met clinical criteria for weed reliance or misuse

0 1395

 

Earlier this week, a ton of support for a cross-party Federal bill that would fully allow for medical marijuana to be both cultivated and prescribed to patients next year has generated. So far, all has been going well but it seems as if there may still be some things to worry about in that not all issues may have been touched upon. It seems as if the biggest issue lies within the fact that the process has been very slow and the bill would only apply to a small group of people. This means that it would not have much of an effect on those that currently need to access medical marijuana through the black market.

Greens leader, Senator Richard Di Natale, stated on Monday that the Bill to make a regulator for medical marijuana for specific conditions has already been made and would be voted upon by the Senate in November. Sources say that the Bill is even supported by the Prime Minister. Victoria and NSW state governments have made it clear that they would like to legalize medical marijuana, however, a regulation scheme from the federal government is needed in order to issue farmer licenses and permit doctors to prescribe it. Queensland shall “be a kind of offsider, joining in on any ventures the southern states start.”

This week’s moves make it clear that the benefits of medical marijuana are copious yet neither the substances nor the supply lines are legalized for those who need these benefits. The moves also restrict those who would be allowed to have it greatly. Basically, the move may be good for years to come, but not for right now. The Victorian Government has promised that they would have set up an Office of Medicinal Cannabis by the end of this year into order to conduct research, develop, and dispense marijuana products through pharmacies to those allowed to receive medical marijuana.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements